The European Lambert–Eaton Myasthenic Syndrome Registry: Long-Term Outcomes Following Symptomatic Treatment

INTRODUCTION: Lambert–Eaton myasthenic syndrome (LEMS) is characterized by autoantibodies against voltage-gated calcium channels (VGCC) at the neuromuscular junction causing proximal muscle weakness, decreased tendon reflexes, and autonomic changes. The European LEMS registry aimed to collate observ...

Descripción completa

Detalles Bibliográficos
Autores principales: Meisel, Andreas, Sieb, Jörn P., Le Masson, Gwendal, Postila, Ville, Sacconi, Sabrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338181/
https://www.ncbi.nlm.nih.gov/pubmed/35511347
http://dx.doi.org/10.1007/s40120-022-00354-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338181/
https://www.ncbi.nlm.nih.gov/pubmed/35511347
http://dx.doi.org/10.1007/s40120-022-00354-8

Ejemplares similares